195 related articles for article (PubMed ID: 23010903)
1. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
Nistico JA; Hage JE; Schoch PE; Cunha BA
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903
[TBL] [Abstract][Full Text] [Related]
2. Is repeat PCR needed for diagnosis of Clostridium difficile infection?
Luo RF; Banaei N
J Clin Microbiol; 2010 Oct; 48(10):3738-41. PubMed ID: 20686078
[TBL] [Abstract][Full Text] [Related]
3. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.
Luna RA; Boyanton BL; Mehta S; Courtney EM; Webb CR; Revell PA; Versalovic J
J Clin Microbiol; 2011 Mar; 49(3):851-7. PubMed ID: 21209161
[TBL] [Abstract][Full Text] [Related]
4. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
Deak E; Miller SA; Humphries RM
J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
[TBL] [Abstract][Full Text] [Related]
7. Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.
Janezic S; Strumbelj I; Rupnik M
J Clin Microbiol; 2011 Aug; 49(8):3024-5. PubMed ID: 21632902
[TBL] [Abstract][Full Text] [Related]
8. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection.
Knetsch CW; Bakker D; de Boer RF; Sanders I; Hofs S; Kooistra-Smid AM; Corver J; Eastwood K; Wilcox MH; Kuijper EJ
J Clin Microbiol; 2011 Jan; 49(1):227-31. PubMed ID: 20980562
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
10. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection: monoclonal or polyclonal genesis?
Hell M; Permoser M; Chmelizek G; Kern JM; Maass M; Huhulescu S; Indra A; Allerberger F
Infection; 2011 Oct; 39(5):461-5. PubMed ID: 21826436
[TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
Nolte FS; Ribeiro-Nesbitt DG
J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
[TBL] [Abstract][Full Text] [Related]
13. Comparison of rectal swabs and fecal samples for the detection of
Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
15. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
Chang FC; Liu CP; Sun FJ; Lin CC
J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.
Green DA; Stotler B; Jackman D; Whittier S; Della-Latta P
J Clin Microbiol; 2014 Nov; 52(11):3853-5. PubMed ID: 25122866
[TBL] [Abstract][Full Text] [Related]
19. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
[TBL] [Abstract][Full Text] [Related]
20. Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.
Culbreath K; Ager E; Nemeyer RJ; Kerr A; Gilligan PH
J Clin Microbiol; 2012 Sep; 50(9):3073-6. PubMed ID: 22718938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
